Langerhans' cells (LC) were investigated immunohistochemically and electron microscopically in normal equine epidermis and 133 equine cutaneous papillomas experimentally induced in five 2-year-old Thoroughbred horses. Class II major histocompatibility complex antigen-positive dendritic LC were found in the normal epidermis and ultrastructurally had the characteristic Birbeck's granules. In the developing phase of the papillomas, LC were significantly decreased in number and size, indicative of a hypofunctional state. In the regressing phase of the papillomas, LC were markedly increased in number, especially at the epidermis-dermis junction. LC with long dendrites were rich in cytoplasm with well-developed cytoplasmic organelles, including Golgi apparatus, lysosomes, Birbeck's granules, and multivesicular bodies. These LC were hyperfunctional. An infiltration of many T lymphocytes was also observed at the epidermis-dermis junction.
BelsitoDVFlotteTJLimHWBaerRLThorbeckeGJGigliI:
Effect of glucocorticoids on epidermal Langerhans' cell.
J Exp Med155:
291–302,
1982.
2.
BryanLAGriebelPJHainesDMDavisWCAllenJR:
Immunocytochemical identification of bovine Langerhans cells by use of a monoclonal antibody directed against class II MHC antigens.
J Histochem Cytochem36:
991–995,
1988.
3.
ChardonnetYViacJThivoletJ:
Langerhans cells in human wart lesions.
Br J Dermatol115:
669–675,
1986.
4.
DohertyPC:
T cells and viral infections.
Br Med Bull41:
7–14,
1985.
5.
FriedmanPS:
Disappearance of epidermal Langerhans' cells during PUVA therapy.
Br J Dermatol105:
219–221,
1981.
6.
FrueMKatzSI:
Direct effects of glucocorticosteroids on epidermal Langerhans cells.
J Invest Dermatol92:
342–347,
1989.
7.
GatterKCMorrisHBRoachBMortimerPFlemingKAMasonDY:
Langerhans cells and T cells in human skin tumors: an immunohistochemical study.
Histopathology8:
229–244,
1984.
8.
GoordyalPIsaacsonPG:
Immunocytochemical characterization of monocyte colonies of human bone marrow: a clue to the origin of Langerhans cells and interdigitating reticulum cells.
J Pathol146:
189–195,
1985.
9.
HunzikerNWinkelmannRK:
Langerhans cells in contact dermatitis of the guinea pig.
Arch Dermatol114:
1309–1313,
1978.
10.
KatzSITamakiKSachsD:
Epidermal Langerhans cells are derived from cells originating in bone marrow.
Nature282:
324–326,
1979.
11.
KlareskogLTjernlundUMForsumUPetersonPA:
Epidermal Langerhans cells express Ia antigen.
Nature268:
248–250,
1977.
12.
LeeAKYEisingerM:
Cell mediated immunity (CMI) to human wart virus and wart-associated tissue antigens.
Clin Exp Immunol26:
419–424,
1976.
13.
LiottaLAAbeSRobeyPGMartinGR:
Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor.
Proc Natl Acad Sci USA76:
2268–2272,
1979.
14.
McArdleJPMullerHK:
Quantitative assessment of Langerhans' cells in human cervical intraepithelial neoplasia and wart virus infection.
Am J Obstet Gynecol154:
509–515,
1986.
15.
MorrisHHBGatterKCSteinHMasonDY:
Langerhans' cells in human cervical epithelium: an immunohistological study.
Br J Obstet Gynecol90:
400–411,
1983.
ObataMTagamiH:
Alteration in murine epidermal Langerhans cell population by various UV irradiations: quantitative and morphologic studies on the effects of various wave lengths of monochromatic radiation on Iabearing cells.
J Invest Dermatol84:
139–145,
1985.
19.
RowdenGLewisMGSullivanAK:
Ia antigen on human epidermal Langerhans cells.
Nature268:
247–248,
1977.
20.
SauderDNDinarelloCAMorhennVB:
Langerhans' cell production of interleukin-1.
J Invest Dermatol82:
605–607,
1984.
21.
ShelleyWBJuhlinL:
The Langerhans cell: its origin, nature, and function.
Acta Derm Venereol Suppl (Stockh)79:
7–22,
1978.
22.
Silberberg-SinakinIGilgiIBaerRLThorbeckeGJ:
Langerhans' cells: role in contact hypersensitivity and relationship to lymphoid dendritic cells and to macrophages.
Immunol Rev53:
203–232,
1980.
StinglGKatzSIShevachEMWolff-SchreinerECGreenI:
Detection of Ia antigens on Langerhans cells in guinea pig skin.
J Immunol120:
570–578,
1978.
25.
StinglGWolff-SchreinerECPichlerWJGschnaitFKnappWWolffK:
Epidermal Langerhans cells bear Fc and C3 receptors.
Nature268:
245–246,
1977.
26.
StreileinJWBergstresserPR:
Ia antigen and epidermal Langerhans cells.
Transplantation30:
319–323,
1980.
27.
StreileinJWGrammerSF:
In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes.
J Immunol143:
3925–3933,
1989.
28.
SudoSSaitoAMorohashiM:
Immunohistochemical study of Langerhans cells in skin tumors.
Dermatologica174:
76–83,
1987.
29.
SundbergJP:
Papillomavirus infections in animals. In:
Papillomaviruses and Human Disease,
ed. SyrjanenKGissmannLKossLG,
pp. 40–103.
Springer-Verlag, New York, NY,
1987.
30.
TamakiKStinglGGullinoMSachsDHKatzSI:
Ia antigens in mouse skin are predominantly expressed on Langerhans cells.
J Immunol123:
784–787,
1979.
31.
ThivoletJViacJStaquetMJ:
Cell mediated immunity in wart infection.
Int J Dermatol21:
94–98,
1982.
32.
TigalonowaMBjerkeJRMatreR:
Fcγ-receptor as a functional marker on epidermal Langerhans' cells in situ.
Acta Derm Venereol (Stockh)69:
477–481,
1989.
33.
ViacJHaftekMChardonnetY:
Langerhans cells and human papillomavirus infections. In:
The Langerhans Cell,
ed. ThivoletJSchmittD,
pp. 449–460.
John Libbey Eurotext Ltd, Paris, France,
1988.
34.
WalterMGissmannLZentgrafHKirchnerH:
Measurement of cell-mediated immunity against bovine papilloma virus by lymphoproliferative reactions.
Immunobiology174:
244–250,
1987.
35.
WoodGSTurnerRRShiurbaRAEngLWarnkeRA:
Human dendritic cells and macrophages: in situ immunophenotypic definition of subsets that exhibit specific morphologic and microenvironmental characteristics.
Am J Pathol119:
73–82,
1985.
